MET and Small-Cell Lung Cancer

Por Gelsomino, Francesco, Rossi, Giulio, Tiseo, Marcello
Publicado no Cancers (Basel) (2014)

Clinical implications and future perspectives in testing non-small cell lung cancer (NSCLC) for anaplastic lymphoma kinase (ALK) gene rearrangements

Por Gelsomino, Francesco, Rossi, Giulio, Tiseo, Marcello
Publicado no J Thorac Dis (2015)

Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance

Por Minari, Roberta, Bordi, Paola, Tiseo, Marcello
Publicado no Transl Lung Cancer Res (2016)

“Pseudo-Cavitation” in Thymic Carcinoma during Treatment with Sunitinib

Por Tiseo, Marcello, Rajan, Arun, Thomas, Anish, Giaccone, Giuseppe
Publicado em 2013

Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case report

Por Bordi, Paola, Tiseo, Marcello, Baldari, Giorgio, Buti, Sebastiano
Publicado no BMC Cancer (2016)

Circulating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancer

Por Bordi, Paola, Del Re, Marzia, Danesi, Romano, Tiseo, Marcello
Publicado no Transl Lung Cancer Res (2015)

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors

Por Facchinetti, Francesco, Tiseo, Marcello, Di Maio, Massimo, Graziano, Paolo, Bria, Emilio, Rossi, Giulio, Novello, Silvia
Publicado no Transl Lung Cancer Res (2016)

Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM)

Por Di Maio, Massimo, Bruzzi, Paolo, Perrone, Francesco, Torri, Valter, Montemurro, Filippo, Tiseo, Marcello, Vasile, Enrico
Publicado no ESMO Open (2016)

Italian multicenter survey to evaluate the opinion of patients and their reference clinicians on the “tolerance” to targeted therapies already available for non-small cell lung can...

Por Novello, Silvia, Capelletto, Enrica, Cortinovis, Diego, Tiseo, Marcello, Galetta, Domenico, Valmadre, Giuseppe, Casartelli, Clelia, Rapetti, Simonetta Grazia, Rossi, Antonio
Publicado no Transl Lung Cancer Res (2014)

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

Por Walleser, Silke, Ray, Joshua, Bischoff, Helge, Vergnenègre, Alain, Rosery, Hubertus, Chouaid, Christos, Heigener, David, de Castro Carpeño, Javier, Tiseo, Marcello, Walzer, Stefan
Publicado em 2012

Maintenance therapy in NSCLC: why? To whom? Which agent?

Por Maione Paolo, Garassino Marina, Di Maio Massimo, Cortinovis Diego, Banna Giuseppe, Tiseo Marcello, Milella Michele, Novello Silvia, Martelli Olga, Vavalà Tiziana, Bria Emilio
Publicado em 2011-05-01

Expression Levels of Some Antioxidant and Epidermal Growth Factor Receptor Genes in Patients with Early-Stage Non-Small Cell Lung Cancer

Por De Palma, Giuseppe, Mozzoni, Paola, Acampa, Olga, Internullo, Eveline, Carbognani, Paolo, Rusca, Michele, Goldoni, Matteo, Corradi, Massimo, Tiseo, Marcello, Apostoli, Pietro, Mutti, Antonio
Publicado em 2010

Maintenance therapy in NSCLC: why? To whom? Which agent?

Por Novello, Silvia, Milella, Michele, Tiseo, Marcello, Banna, Giuseppe, Cortinovis, Diego, Di Maio, Massimo, Garassino, Marina, Maione, Paolo, Martelli, Olga, Vavalà, Tiziana, Bria, Emilio
Publicado em 2011

Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines

Por Galetti, Maricla, Petronini, Pier Giorgio, Fumarola, Claudia, Cretella, Daniele, La Monica, Silvia, Bonelli, Mara, Cavazzoni, Andrea, Saccani, Francesca, Caffarra, Cristina, Andreoli, Roberta, Mutti, Antonio, Tiseo, Marcello, Ardizzoni, Andrea, Alfieri, Roberta R.
Publicado no PLoS One (2015)

CT-guided biopsy of pulmonary nodules: is pulmonary hemorrhage a complication or an advantage?

Por De Filippo, Massimo, Saba, Luca, Silva, Mario, Zagaria, Raffaella, Concari, Giorgio, Nizzoli, Rita, Bozzetti, Cecilia, Tiseo, Marcello, Ardizzoni, Andrea, Lipia, Stefano, Paladini, Ilaria, Macarini, Luca, Carrafiello, Giampaolo, Brunese, Luca, Rotondo, Antonio, Rossi, Cristina
Publicado no Diagn Interv Radiol (2014)

Gefitinib Inhibits Invasive Phenotype and Epithelial-Mesenchymal Transition in Drug-Resistant NSCLC Cells with MET Amplification

Por La Monica, Silvia, Caffarra, Cristina, Saccani, Francesca, Galvani, Elena, Galetti, Maricla, Fumarola, Claudia, Bonelli, Mara, Cavazzoni, Andrea, Cretella, Daniele, Sirangelo, Rita, Gatti, Rita, Tiseo, Marcello, Ardizzoni, Andrea, Giovannetti, Elisa, Petronini, Pier Giorgio, Alfieri, Roberta R.
Publicado em 2013

Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance

Por Cretella, Daniele, Saccani, Francesca, Quaini, Federico, Frati, Caterina, Lagrasta, Costanza, Bonelli, Mara, Caffarra, Cristina, Cavazzoni, Andrea, Fumarola, Claudia, Galetti, Maricla, La Monica, Silvia, Ampollini, Luca, Tiseo, Marcello, Ardizzoni, Andrea, Petronini, Pier Giorgio, Alfieri, Roberta R
Publicado em 2014

Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines

Por Alfieri, Roberta R, Galetti, Maricla, Tramonti, Stefano, Andreoli, Roberta, Mozzoni, Paola, Cavazzoni, Andrea, Bonelli, Mara, Fumarola, Claudia, La Monica, Silvia, Galvani, Elena, De Palma, Giuseppe, Mutti, Antonio, Mor, Marco, Tiseo, Marcello, Mari, Ettore, Ardizzoni, Andrea, Petronini, Pier Giorgio
Publicado em 2011

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

Por Cavazzoni, Andrea, Alfieri, Roberta R, Cretella, Daniele, Saccani, Francesca, Ampollini, Luca, Galetti, Maricla, Quaini, Federico, Graiani, Gallia, Madeddu, Denise, Mozzoni, Paola, Galvani, Elena, La Monica, Silvia, Bonelli, Mara, Fumarola, Claudia, Mutti, Antonio, Carbognani, Paolo, Tiseo, Marcello, Barocelli, Elisabetta, Petronini, Pier Giorgio, Ardizzoni, Andrea
Publicado em 2012

Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA

Por Del Re, Marzia, Tiseo, Marcello, Bordi, Paola, D'Incecco, Armida, Camerini, Andrea, Petrini, Iacopo, Lucchesi, Maurizio, Inno, Alessandro, Spada, Daniele, Vasile, Enrico, Citi, Valentina, Malpeli, Giorgio, Testa, Enrica, Gori, Stefania, Falcone, Alfredo, Amoroso, Domenico, Chella, Antonio, Cappuzzo, Federico, Ardizzoni, Andrea, Scarpa, Aldo, Danesi, Romano
Publicado no Oncotarget (2016)